Pharmacogenomics
RX Note
DECEMBER 25, 2024
In 2007, FDA changed the labelling requirement for warfarin, advising that a lower initial dose should be considered in people with certain genetic variations. Tramadol is metabolised by CYP2D6 to its active metabolite: 6-10% of Caucasians and 1-2% of Asians lack CYP2D6 and may not obtain pain relief.
Let's personalize your content